CSF2 and COVID-19: It has been proposed that CSF can be used as an early warning marker of whether COVID-19 causes myocardial injury (64), or to treat COVID-19 by interfering with the CSF pathway (65), but neither CSF nor CSF3 was found in the results of our analysis of human single-cell data.